| Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study COVIDSurg Collaborative Anaesthesia 76 (6), 748-758, 2021 | 550* | 2021 |
| Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study G Ferrandina, G Mantegna, M Petrillo, G Fuoco, L Venditti, S Terzano, ... Gynecologic oncology 124 (3), 389-394, 2012 | 175 | 2012 |
| Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept M Petrillo, G Vizzielli, F Fanfani, V Gallotta, F Cosentino, V Chiantera, ... Gynecologic oncology 139 (1), 5-9, 2015 | 152 | 2015 |
| Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery G Ferrandina, PA Margariti, D Smaniotto, M Petrillo, MG Salerno, A Fagotti, ... Gynecologic oncology 119 (3), 404-410, 2010 | 143 | 2010 |
| Targeting CD133 antigen in cancer G Ferrandina, M Petrillo, G Bonanno, G Scambia Expert opinion on therapeutic targets 13 (7), 823-837, 2009 | 132 | 2009 |
| Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy M Distefano, S Riccardi, G Capelli, B Costantini, M Petrillo, C Ricci, ... Gynecologic oncology 111 (1), 144-150, 2008 | 131 | 2008 |
| Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case–control study on survival in patients with two year follow-up A Fagotti, B Costantini, M Petrillo, G Vizzielli, F Fanfani, PA Margariti, ... Gynecologic oncology 127 (3), 502-505, 2012 | 129 | 2012 |
| CD133 antigen expression in ovarian cancer G Ferrandina, E Martinelli, M Petrillo, MG Prisco, G Zannoni, S Sioletic, ... BMC cancer 9, 1-9, 2009 | 123 | 2009 |
| CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy F de Nigris, V Crudele, A Giovane, A Casamassimi, A Giordano, ... Proceedings of the National Academy of Sciences 107 (32), 14484-14489, 2010 | 122 | 2010 |
| SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. C COVIDSurg, C GlobalSurg Anaesthesia 77 (1), 28-39, 2022 | 100 | 2022 |
| Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis G Mantegna, M Petrillo, G Fuoco, L Venditti, S Terzano, LP Anchora, ... BMC cancer 13, 1-8, 2013 | 100 | 2013 |
| Polarisation of tumor-associated macrophages toward M2 phenotype correlates with poor response to chemoradiation and reduced survival in patients with locally advanced cervical … M Petrillo, GF Zannoni, E Martinelli, L Pedone Anchora, G Ferrandina, ... PloS one 10 (9), e0136654, 2015 | 98 | 2015 |
| Microwave ablation of pancreatic head cancer: safety and efficacy G Carrafiello, AM Ierardi, F Fontana, M Petrillo, C Floridi, N Lucchina, ... Journal of Vascular and Interventional Radiology 24 (10), 1513-1520, 2013 | 93 | 2013 |
| Evaluation of quality of life and emotional distress in endometrial cancer patients: a 2-year prospective, longitudinal study G Ferrandina, M Petrillo, G Mantegna, G Fuoco, S Terzano, L Venditti, ... Gynecologic oncology 133 (3), 518-525, 2014 | 87 | 2014 |
| Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer M Petrillo, GF Zannoni, L Tortorella, LP Anchora, V Salutari, A Ercoli, ... American journal of obstetrics and gynecology 211 (6), 632. e1-632. e8, 2014 | 84 | 2014 |
| Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts P Todeschini, E Salviato, L Paracchini, M Ferracin, M Petrillo, L Zanotti, ... Cancer Letters 388, 320-327, 2017 | 83 | 2017 |
| Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness G Raspaglio, M Petrillo, E Martinelli, DDL Puma, M Mariani, M De Donato, ... Gene 542 (2), 173-181, 2014 | 82 | 2014 |
| Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer A Ciucci, GF Zannoni, D Travaglia, M Petrillo, G Scambia, D Gallo Gynecologic oncology 132 (2), 351-359, 2014 | 78 | 2014 |
| BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study M Petrillo, C Marchetti, R De Leo, A Musella, E Capoluongo, I Paris, ... American journal of obstetrics and gynecology 217 (3), 334. e1-334. e9, 2017 | 77 | 2017 |
| Timing and pattern of recurrence in ovarian cancer patients with high tumor dissemination treated with primary debulking surgery versus neoadjuvant chemotherapy M Petrillo, G Ferrandina, A Fagotti, G Vizzielli, PA Margariti, AL Pedone, ... Annals of surgical oncology 20, 3955-3960, 2013 | 77 | 2013 |
